| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/23/2005 | US20050136107 Hydrophilic ydroxypropyl (methyl) cellulose, , hydroxyethyl cellulose, methyl cellulose, sodium carboxymethyl cellulose, polyvinyl alcohol, sodium alginate, polyvinylpyrrolidone, crotonic acid-vinyl acetate copolymer, maleic anhydride-methyl vinyl ether copolymer, polyoxyethylene glycol; low viscosity |
| 06/23/2005 | US20050136106 Therapeutic placebo enhancement of commonly used medications |
| 06/23/2005 | US20050136105 Consumer customized dosage forms |
| 06/23/2005 | US20050136104 Chewable soft capsules containing ungelatinized starch |
| 06/23/2005 | US20050136103 Compositions capable of facilitating penetration across a biological barrier |
| 06/23/2005 | US20050136102 Enhanced transport using membrane disruptive agents |
| 06/23/2005 | US20050136101 Therapeutic system containing an active substance for the application on the skin which contains at least two polymerous layers |
| 06/23/2005 | US20050136099 Woven or non-woven fibrous web; microbeads; water-insoluble substrate |
| 06/23/2005 | US20050136097 Soft paper-based products |
| 06/23/2005 | US20050136095 For placement in the eye; includes a drug core and its holder |
| 06/23/2005 | US20050136094 Drug delivery device with mesh based suture tab |
| 06/23/2005 | US20050136091 Crosslinkable macromers |
| 06/23/2005 | US20050136085 Panthenol and natural organic extracts for reducing skin irritation |
| 06/23/2005 | US20050136084 Gel sheet and preparation method thereof |
| 06/23/2005 | US20050136081 Storage stability and high viscosity |
| 06/23/2005 | US20050136073 Use of microparticles combined with submicron oil-in-water emulsions |
| 06/23/2005 | US20050136064 Liposomal composition composed of pre-formed liposomes having entrapped therapeutic agent and plurality of targeting conjugates composed of lipid, hydrophilic polymer and targeting ligand; target-cell sensitized liposome composition formed by incubating liposomal composition with selected conjugate |
| 06/23/2005 | US20050136040 Peptide nucleic acid of a nucleic acid binding portion and a repressor portion of a polypeptide or peptidomimetic; drug design; gene expression inhibition |
| 06/23/2005 | US20050136023 Electrically conductive adhesive hydrogels with a thermally activated chemical initiator |
| 06/23/2005 | US20050136010 Treatment of chronic obstructive pulmonary disease, by administering inhalant with particulate carrier or diluent selecting from saccharide, a sugar alcohol or lactose, in an amount of from 400 mu g to 5000 mu g per mu g of active ingredient |
| 06/23/2005 | US20050136009 metered dosage inhaler having a metering valve to drug deliver a dose of aerosol suspension formulations comprising mometasone furoate, Formoterol, Formoterol Fumarate and HFA 227; drug delivery device |
| 06/23/2005 | US20050136002 Use of particulate contrast agents in diagnostic imaging for studying physiological paramaters |
| 06/23/2005 | DE20023640U1 Detecting an embryonic cell surface marker e.g. cartilage-derived morphogenic protein CDMP-1 so as to positively identify viable precursor cells that have entered a post-natal differentiation pathway |
| 06/23/2005 | DE10356346A1 Erfindung betreffend Prophylaxe und Therapie von Erkrankungen, die durch Thrombusbildung verusacht oder mit versacht werden Concerning invention prophylaxis and therapy of diseases verusacht by thrombus or plunged |
| 06/23/2005 | DE10356248A1 Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden A pharmaceutical composition for the treatment of rhinitis |
| 06/23/2005 | DE10355461A1 Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases |
| 06/23/2005 | DE10355251A1 Water-based pharmaceutical preparation for treatment of tumors has active ingredient effective against receptor of endothelial growth factor receptor |
| 06/23/2005 | CA2549572A1 Taste masked pharmaceutical compositions comprising bitter drug and ph sensitive polymer |
| 06/23/2005 | CA2549539A1 Taste masked pharmaceutical composition comprising ph sensitive polymer |
| 06/23/2005 | CA2549391A1 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 06/23/2005 | CA2549195A1 Bioadhesive polymers with catechol functionality |
| 06/23/2005 | CA2548892A1 Compositions for treatment of ear disorders and methods of use thereof |
| 06/23/2005 | CA2548822A1 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 06/23/2005 | CA2548596A1 Method of treatment for undesired effect following transdermal or topical drug delivery |
| 06/23/2005 | CA2548559A1 Intranasal compositions comprising granisetron and chitosan |
| 06/23/2005 | CA2548446A1 Compounds for the treatment of dryness of the ocular surface caused by photorefractive surgery |
| 06/23/2005 | CA2548281A1 Method of preparation of mixed phase co-crystals with active agents |
| 06/23/2005 | CA2548144A1 Dosing methods for .beta.-d-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy |
| 06/23/2005 | CA2548132A1 Powder containing low-molecular dextran and method for producing the same |
| 06/23/2005 | CA2548033A1 Methods and composition for transplantation of dopaminergic neurons for parkinson's disease |
| 06/23/2005 | CA2547673A1 Device for dosing a product that is intended to be applied to the skin |
| 06/23/2005 | CA2547621A1 Transdermal system for sustained delivery of polypeptides |
| 06/23/2005 | CA2545979A1 Administration form based on crosslinked hydrophilic polymers |
| 06/22/2005 | EP1543851A1 Implantable active agent delivery device |
| 06/22/2005 | EP1543848A1 High strength suture with absorbable core and suture anchor combination |
| 06/22/2005 | EP1543841A1 Soild nano pharmaceutical formulation and preparation method thereof |
| 06/22/2005 | EP1543840A1 Drug absorbability improving agents |
| 06/22/2005 | EP1543836A1 Recombinant Vibrio cholerae strain and vaccine comprising said strain |
| 06/22/2005 | EP1543831A1 Pregabalin composition |
| 06/22/2005 | EP1543830A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 06/22/2005 | EP1543828A1 Gel sheet and preparation method thereof |
| 06/22/2005 | EP1543827A1 Emulsion of perfluororganic compounds exhibiting gas-transport properties, a surface-active agent for said emulsion and method for the production thereof |
| 06/22/2005 | EP1543826A1 Concentrated aqueous solution of ambroxol |
| 06/22/2005 | EP1543063A1 Drug delivery |
| 06/22/2005 | EP1543058A1 Water-swellable polymers |
| 06/22/2005 | EP1543040A1 Solubilising polysaccharides substituted with hydrophilic and hydrophobic groups |
| 06/22/2005 | EP1542961A1 Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 06/22/2005 | EP1542904A1 Process for producing metered dose inhaler formulations |
| 06/22/2005 | EP1542903A2 Packaging and dispensing of rapid dissolve dosage form |
| 06/22/2005 | EP1542788A1 Nanodevice for controlled charged particle flow and method for producing same |
| 06/22/2005 | EP1542753A1 Pharmaceutical compositions |
| 06/22/2005 | EP1542728A1 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same |
| 06/22/2005 | EP1542717A1 Improvements in or relating to vaccines |
| 06/22/2005 | EP1542712A2 Glp-1 formulations with protracted time action |
| 06/22/2005 | EP1542705A1 Anticoagulant composition |
| 06/22/2005 | EP1542697A1 Modified release formulations of oxcarbazepine and derivatives thereof |
| 06/22/2005 | EP1542695A1 Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer. |
| 06/22/2005 | EP1542668A2 Aripiprazole complex formulation and method |
| 06/22/2005 | EP1542666A1 Modafinil pharmaceutical compositions |
| 06/22/2005 | EP1542663A1 A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 06/22/2005 | EP1542662A1 Immediate release dosage form comprising shell having openings therein |
| 06/22/2005 | EP1542661A1 Modified release dosage form with two cores |
| 06/22/2005 | EP1542660A1 Sustained released delivery of amphetamine salts |
| 06/22/2005 | EP1542659A1 Process for coating a pharmaceutical particle |
| 06/22/2005 | EP1542658A1 Pharmaceutical compositions |
| 06/22/2005 | EP1542657A1 Cannabinoid liquid formulations for mucosal amdinistration |
| 06/22/2005 | EP1542656A1 Antibiotic product, use and formulation thereof |
| 06/22/2005 | EP1542628A1 Medicinal product packaging |
| 06/22/2005 | EP1542556A2 Antimicrobial body covering articles |
| 06/22/2005 | EP1542553A2 A chemical carrier based on a beta-limit dextrin |
| 06/22/2005 | EP1542531A1 Aqueous fludarabine phosphate composition |
| 06/22/2005 | EP1343592B1 Electrostatic application of powder material to solid dosage forms in an electric field |
| 06/22/2005 | EP1305057B1 Microparticulate biomaterial composition of hyaluronic acid for medical use |
| 06/22/2005 | EP1276386B1 Chewing gum containing encapsulated abrasive filler substance |
| 06/22/2005 | EP1250189B1 Method for modifying the surfaces of fine-porous adsorbents |
| 06/22/2005 | EP1231941B1 Tablets comprising micro-organisms and method for preparation of the tablets |
| 06/22/2005 | EP1171136B1 Immunomodulating compositions comprising urea derivatives for use in the treatment of inflammatory diseases |
| 06/22/2005 | EP1150717B1 Sustained release salts of pharmaceutically active peptides and their production |
| 06/22/2005 | EP0993314B1 Syringe and capsule therefor |
| 06/22/2005 | EP0892644B1 In vivo gene transfer methods for wound healing |
| 06/22/2005 | EP0866874B2 Process for the preparation of materials with a high content of isomers of conjugated linoleic acid |
| 06/22/2005 | CN2705183Y Transdermal administration plaster |
| 06/22/2005 | CN2705162Y Multifunction health plaster |
| 06/22/2005 | CN1630724A Compositions and methods for inhibiting expression of a target gene |
| 06/22/2005 | CN1630539A Multiple compartment bag assembly for dialysis fluid |
| 06/22/2005 | CN1630531A Composition comprising immunogenic microparticles |
| 06/22/2005 | CN1630524A 非肠道顺铂乳剂 Cisplatin parenteral emulsion |
| 06/22/2005 | CN1630523A Compositions internal or relevant improvement |
| 06/22/2005 | CN1630521A Oral compositions and methods for prevention, reduction and treatment of radiation injury |
| 06/22/2005 | CN1630513A Hydrodynamically balancing oral drug delivery system with biphasic release |